Matar S, Skah S, Diomande LE, Buss T, Hagland HR, Yadav A, Forstrøm RJ, Dalhus B, Hestdal K, Pettersen RD, Richartz N(2025) Development of a novel bifunctional anti-CD47 fusion protein with improved efficacy and a favorable safety profile Mol Cancer Ther(in press) DOI 10.1158/1535-7163.MCT-24-0917, PubMed 40084615
Dufour D, Zhao X, Chaleil F, Nothnagel PMC, Bjørås M, Lefrançois-Martinez AM, Martinez A, Chymkowitch P(2025) Pharmacological inhibition of SUMOylation with TAK-981 mimics genetic HypoSUMOylation in murine perigonadal white adipose tissue Adipocyte, 14(1), 2474107 DOI 10.1080/21623945.2025.2474107, PubMed 40047287
Mester S, Chan C, Lustig M, Foss S, Jansen JHM, Leangen Herigstad M, Evers M, Nilsen J, Reiding KR, A Damen JM, Burger R, Grevys A, Dalhus B, Valerius T, Sandlie I, Leusen JHW, Andersen JT(2025) Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life PNAS Nexus, 4(2), pgaf042 DOI 10.1093/pnasnexus/pgaf042, PubMed 40041621
Professor Magnar Bjørås, Department of Microbiology Oslo University Hospital Rikshospitalet PO Box 4950 Nydalen NO-0424 Oslo, Norway Tel: +47 23074059, E-mail: magnar.bjoras@ntnu.no / magnar.bjoras@medisin.uio.no
